DISCOVER THE LATEST
DEVELOPMENTS IN
CEREBRAL EMBOLIC
PROTECTION

Complete the following information to

REGISTER FOR
THIS EVENT

date Thursday, May 23rd, 2019

12:15pm – 1:15pm

EuroPCR 2019

Room 252B Palais des Congres Paris, France

CHAIRS

Andreas-Baumbach_0000_Layer-2

ANDREAS BAUMBACH

MD, Bristol Heart Institute – Bristol, United Kingdom

Alexandra-Lansky_0000_Layer-3

ALEXANDRA LANSKY

MD, Yale School of Medicine, New Haven, CT

FACULTY

AGENDA

Thursday, May 23rd, 2019

12:15

Session objectives – Andreas Baumbach, MD

01

12:20

US REFLECT phase II trial update – Tamim Nazif, MD

02

12:37

EU experience with the TriGUARD 3 CEP device –Michiel Voskuil, MD

03

12:54

CEP Clinical Trials, What’s Next? Keystone Heart’s EU Roadmap – Holger Thiele, MD

04

13:11

Session evaluation and key learnings – Alexandra Lansky, MD

05

The TriGUARD 3™ Cerebral Embolic Protection Device is for Investigational Use Only and not commercially available